Siteone Therapeutics
UEI: ZKBYHMUQS291
• CAGE: 61AQ1
Overview
Awardee Type
Parent
Name
Siteone Therapeutics
Headquarters
South San Francisco, CA
United States
United States
Most Recent Award
May 15, 2023
Calculating
Federal grant recipient
SITEONE THERAPEUTICS, INC.
(UEI ZKBYHMUQS291, CAGE 61AQ1)
is headquartered in South San Francisco CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2010 and
federally registered in
June 2010.
Federal Award Analysis
Siteone Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SITEONE THERAPEUTICS, INC.
UEI
ZKBYHMUQS291
CAGE Code
61AQ1
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 1, 2010
Initial Registration
June 9, 2010
Last Registration
Nov. 19, 2025
Registration Activation
Nov. 21, 2024
Registration Expiration
Nov. 19, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No